Resected High-Risk Rectal GIST Harboring NTRK1 Fusion: a Case Report and Review of the Literature
- PMID: 32506289
- DOI: 10.1007/s12029-020-00423-x
Resected High-Risk Rectal GIST Harboring NTRK1 Fusion: a Case Report and Review of the Literature
References
-
- Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382:973–83. https://doi.org/10.1016/S0140-6736(13)60106-3 . - DOI - PubMed
-
- Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11:865–78. https://doi.org/10.1038/nrc3143 . - DOI - PubMed
-
- Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007;369:1731–41. https://doi.org/10.1016/S0140-6736(07)60780-6 . - DOI - PubMed
-
- Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol. 2006;24:4764–74. - DOI
-
- Shi E, Chmielecki J, Tang CM, Wang K, Heinrich MC, Kang G, et al. FGFR1 and NTRK3 actionable alterations in "wild-type" gastrointestinal stromal tumors. J Transl Med. 2016;14:339. - DOI